← Evidence map

ArticleOncotarget2019

Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma

Elgilda Musi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2019
2020
2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31320995